-arone
A stem from WHO's 2024 stem book.
- Drugs ending in -arone: 7
- Approved somewhere: 4
- With a US drug page: 2
- Stem
- -arone
- Class
- WHO gives no class for this stem
- Most common targets
- KCNH2 (1), Voltage-gated L-type calcium channel (1), Sodium channel alpha subunit (1), KCNJ2 (1), HCN4 (1), SLC22A12 (1), CALM1 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -arone, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Amiodarone | Approved | KCNH2 | HERG blocker |
| Dronedarone | Approved | Voltage-gated L-type calcium channel, Sodium channel alpha subunit, KCNJ2, HCN4 | Voltage-gated L-type calcium channel blocker |
| Benzbromarone | Approved | SLC22A12 | Solute carrier family 22 member 12 inhibitor |
| Benziodarone | Approved | CALM1 | Calmodulin inhibitor |
| Budiodarone | Phase 2 | — | Unknown |
| Celivarone | Phase 2 | — | Unknown |
| Benzarone | — | — | Unknown |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO